Juva Life Inc.
JUVAF
$0.00
$0.000.00%
OTC PK
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Revenue | 42.98% | 9.38% | 42.66% | 49.03% | 87.25% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 42.98% | 9.38% | 42.66% | 49.03% | 87.25% |
| Cost of Revenue | 39.05% | 36.90% | 97.05% | 117.31% | 122.03% |
| Gross Profit | 64.66% | -79.00% | -95.31% | -96.45% | 0.48% |
| SG&A Expenses | -40.14% | -41.60% | -31.49% | -23.07% | -28.10% |
| Depreciation & Amortization | -75.49% | 39.39% | 3.67% | -26.08% | -31.37% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -14.60% | -12.98% | 2.64% | 4.76% | -7.39% |
| Operating Income | 49.59% | 27.20% | 16.91% | 12.07% | 29.15% |
| Income Before Tax | 29.72% | -8.77% | 0.70% | 8.06% | 48.54% |
| Income Tax Expenses | 102.99% | 2,249.09% | 40.73% | 68.80% | -33.08% |
| Earnings from Continuing Operations | 28.50% | -10.30% | 0.50% | 7.71% | 48.43% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 28.50% | -10.30% | 0.50% | 7.71% | 48.43% |
| EBIT | 49.59% | 27.20% | 16.91% | 12.07% | 29.15% |
| EBITDA | 54.90% | 36.72% | 24.97% | 17.11% | 33.83% |
| EPS Basic | 29.74% | -8.00% | 4.25% | 15.67% | 45.93% |
| Normalized Basic EPS | 43.11% | 10.82% | -1.98% | 16.86% | 44.24% |
| EPS Diluted | 29.74% | -8.00% | 4.25% | 15.67% | 45.93% |
| Normalized Diluted EPS | 43.11% | 10.82% | -1.98% | 16.86% | 44.24% |
| Average Basic Shares Outstanding | 2.01% | 2.03% | 3.53% | 5.64% | -2.83% |
| Average Diluted Shares Outstanding | 2.01% | 2.03% | 3.53% | 5.64% | -2.83% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |